Michelon Francois Roger 4
4 · ENDRA Life Sciences Inc. · Filed Dec 17, 2018
Insider Transaction Report
Form 4
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
- Award
Stock Options
2018-12-13+125,000→ 125,000 totalExercise: $2.25Exp: 2026-12-13→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]These Stock Options become exercisable in three equal annual installments beginning on December 13, 2019.